APA
HAE icon

American Portfolios Advisors’s Haemonetics HAE Stock Holding History

American Portfolios Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-70
Closed -$4.67K – 3503
2021
Q2 		$4.67K Hold
70
– – ﹤0.01% 2845
2021
Q1 		$7.77K Hold
70
– – ﹤0.01% 2498
2020
Q4 		$8.31K Hold
70
– – ﹤0.01% 2190
2020
Q3 		$6.11K Hold
70
– – ﹤0.01% 2189
2020
Q2 		$6.27K Hold
70
– – ﹤0.01% 2139
2020
Q1 		$6.98K Hold
70
– – ﹤0.01% 1958
2019
Q4 		$8.04K Buy
+70
New +$8.47K ﹤0.01% 2086

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

American Portfolios Advisors's HAE Position: Q3 2021 in Review

American Portfolios Advisors sold out of Haemonetics (HAE) in Q3 2021, closing a stake of 70 shares — an estimated $4.67K sold.

American Portfolios Advisors first reported a position in HAE in Q4 2019 and held it in 7 quarters. The position peaked at $8.31K in Q4 2020. 245 funds tracked by Wall St. Rank hold HAE as of Q3 2021.

  • American Portfolios Advisors reported no remaining Haemonetics position as of Q3 2021 after selling out during the quarter.
  • American Portfolios Advisors sold 70 Haemonetics shares in Q3 2021, an estimated $4.67K.
  • American Portfolios Advisors first reported a position in Haemonetics in Q4 2019 and held it in 7 quarters.
  • American Portfolios Advisors's Haemonetics position peaked at $8.31K in Q4 2020.
  • 245 funds tracked by Wall St. Rank held Haemonetics as of Q3 2021.

Based on American Portfolios Advisors's 13F filing for Q3 2021, filed 22 Mar 2023.